Home >

Welcome to ASCO Connection Discussion

ASCO University
Frederick R. Appelbaum, MD, FASCO
Nov 18, 2015 10:11 AM
Welcome to this discussion forum for the Acute Myeloid Leukemia ASCO Tumor Board.  This course discussed a forty-four year old man who presents with fatigue that has been worsening over 3 weeks.  A complete blood count shows a hematocrit of 25%, a white blood cell count of 17,000/mm3 with frequent...
Molecular Oncology Tumor Board
ASCO University
Nov 04, 2015 10:35 AM
User Instructions: Welcome to the Molecular Oncology Tumor Board Series! This educational initiative is a collaboration between the American Society of Clinical Oncology (ASCO), College of American Pathologists (CAP), and Association for Molecular Pathology (AMP).
A new case will be presented each...
ASCO University
Anil K. D'Cruz
Oct 28, 2015 3:56 PM
Welcome to this discussion forum for the Thyroid Cancer ASCO Tumor Board. This course discusses a 35-year-old female who presents with a thyroid nodule marginally increasing in size over two years. She had no family history of thyroid cancer or prior exposure to radiation.  This case presentation...
Molecular Oncology Tumor Board
ASCO University
Oct 14, 2015 10:22 AM
Read more to answer the following questions: 1. In general, would you be more inclined to offer a targeted therapy regimen or an immune therapy regimen? 2. If a BRAF-targeted therapy approach is selected, what therapeutic options are the most appropriate? 3. If an immune-targeted therapy approach...


Tweets from ASCO

Tweets from Oncology Community